View all blogs:
Synthesis, characterisation and degradation of polysorbates in biopharmaceuticals
Pharma
Polysorbates are essential in biologics delivery, serving as crucial emulsifiers and stabilisers for biopharmaceuticals. They enhance solubility, improve bioavailability, and protect proteins from...
Product Spotlight - Crodamol™ CCC Pharma
Pharma
Crodamol™ CCC Pharma is a mild, non-irritating liquid emollient, ideal for sensitive site applications. The excipient can contribute to many benefits for various topical formulations.
Lipid Leaders: Söhnke Voss
Pharma
In this Lipid Leaders interview, we speak to Söhnke Voss, PhD. Söhnke is a lipids expert with over 25 years’ experience in the pharmaceutical industry. Keep reading to learn more about lipids and the...
.png?w=768&la=en-GB&focalpointcrop=1&xratio=0&yratio=0&hash=DED45BB0A21246A9E305B87AC705FA5A)
Protein Delivery Leaders: Andrew Bright
Pharma
In this Protein Delivery Leaders interview, we speak to Andrew Bright, PhD. Keep reading to learn more about breakthroughs in protein delivery and key challenges faced in biologic formulations.
Croda Pharma wins ‘Best Production/Process Development’ Award at the 17th annual Vaccine Industry Excellence awards
Pharma
Croda Pharma has been awarded winner of a prestigious award for its process development for innovative ingredients, including its production of sustainably sourced Squalene to replace shark-derived...
Partnership agreement between Croda and AAHI to drive innovation in vaccine development
Pharma
19 March 2024: Croda International Plc (Croda) and The Access to Advanced Health Institute (AAHI) are pleased to announce today the signing of a partnership agreement around innovation and development...
Croda Foundation announces it has sustainably improved the lives of 22.8 million people – exceeding its 2030 target.
Pharma
Croda Foundation announces it has sustainably improved the lives of 22.8 million people –exceeding its 2030 target.
Product Spotlight - Super Refined PEG 400
Pharma
Super Refined PEG 400 is a highly purified solubiliser is an exemplary excipient in both small molecule and protein formulations containing the most sensitive APIs for treatments of a range of...
Specializing in specific enhancement technologies
Pharma
Croda Pharma specializes in four technologies aimed at improving bioavailability and solubility. Find out more!
Explore our latest downloads!
Pharma
Check out the latest resources from Croda Pharma, available to download today.
Hear directly from our experts...
Pharma
Watch our expert Dr. Kritika Bajaj discuss our product range in more detail and learn how Virodex™ could be the solution to your replacement requirement.
Concerns about Triton™ X-100 have been an ongoing discussion across multiple regulatory authorities around the world
Pharma
Triton™ X-100, a non-ionic surfactant with a hydrophilic polyethylene oxide chain and a hydrophobic aromatic group1, has found widespread use in the biopharmaceutical industry with applications...
“Close the Care Gap” – World Cancer Day 2024
Pharma
We are proud to continue supporting the development of cancer treatments, and on this World Cancer Day, recognise the importance of innovation and science to cure and treat those diagnosed. Together,...
Spotlight on Kritika Bajaj
Pharma
Highlighting the scientists and teams who are involved in our latest product launch, Virodex™, replacements for Triton™ X-100, we sat down with Kritika Bajaj and asked her about her involvement around...
Croda’s response to Sustainable Markets Initiative for supplier sustainability targets
Pharma
The recent open letter from the Sustainable Markets Initiative Health Systems Task Force called for Healthcare supply chains to become greener, more efficient and circular and set out a series of...
Sustainability for vaccines: Decarbonisation of one of our key sites
Pharma
Sustainability is often defined as meeting the needs of those alive today without compromising the ability of future generations to meet their needs. It is a long-term goal that covers three pillars:...
A powerful match - celebrating three years of Croda Pharma and Avanti
Pharma
Today marks three years since we acquired Avanti Polar Lipids. During the COVID-19 pandemic, it became clear that the combination of Avanti's lipid expertise and our manufacturing scale-up capability...
Introducing new bioprocessing solutions to replace banned materials
Pharma
We have introduced a critical range of new bioprocessing detergents optimised for viral inactivation and cell lysis. The company’s new product range, Virodex™, offers an answer to the key market need...
Cholesterol: enhancing stability and efficacy in lipid-based drug delivery
Pharma
Cholesterol, a key component in lipid-based drug delivery systems, provides structural support and stability, enhances the efficiency of intracellular delivery and gene transfection.
Acquisition of Solus Biotech expands specialised Pharma business in Asia
Pharma
05 July 2023: Croda International Plc (‘Croda’) announced that it has acquired Solus Biotech, a global leader in premium, biotechnology-derived materials, from Solus Advanced Materials
Lets connect...
Register to the mailing list to unlock:
- First access to new products, new data and exclusive literature
- Whitepapers and thought provoking content
- Special offers on conference and exhibition passes when available
- Invitations to invite only Croda Pharma events.